68. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico.
69. Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
70. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
71. Там же.
72. Tanaka K, Ishikawa Y, Yokoyama M, et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial.
73. Einvik G, Klemsdal TO, Sandvik L, et al. A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk.
74. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids.
75. DiNicolantonio JJ, Meier P, O’Keefe JH. Omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease: do formulation, dosage & comparator matter?
76. Simopoulos AP, Leaf A, Salem N Jr. Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids.
77. Harris WS, Von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease?
1. Lee KW, Lee HJ, Cho HY, et al. Role of the conjugated linoleic acid in the prevention of cancer.
2. Wang Y, Lu J, Ruth MR, et al. Trans-11 vaccenic acid dietary supplementation induces hypolipidemic effects in JCR: LA-cp rats.
3. Micha R, Mozaffarian D. Trans fatty acids: effects on cardiometabolic health and implications for policy.
4. Kinsella JE, Bruckner G, Mai J, et al. Metabolism of trans fatty acids with emphasis on the effects of trans, trans-octadecadienoate on lipid composition, essential fatty acid, and prostaglandins: an overview.
5. Tardy AL, Morio B, Chardigny JM, et al. Ruminant and industrial sources of trans-fat and cardiovascular and diabetic diseases.
6. Morris MC, Evans DA, Bienias JL, et al. Dietary fats and the risk of incident Alzheimer disease.
7. Chavarro JE, Stampfer MJ, Campos H, et al. A prospective study of trans-fatty acid levels in blood and risk of prostate cancer.
8. Chajes V, Thiebaut AC, Rotival M, et al. Association between serum transmonounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study.
9. Phivilay A, Julien C, Tremblay C, et al. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer’s disease.
10. Golomb BA, Bui AK. A fat to forget: trans fat consumption and memory.
11. Sanchez-Villegas A, Verberne L, De Irala J, et al. Dietary fat intake and the risk of depression: the SUN Project.
12. A scientific discovery which will affect every kitchen in America.
13. Rupp, R. The butter wars: when margarine was pink.
14. Braun, AD. Save Waste Fats.